Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a physician (neurologist) concerning a 15 year old female patient with no drug reactions or allergies and no pertinent medical history who in December 2011, was vaccinated with the first dose of GARDASIL, 0.5 mL, intramuscular in the left deltoid (lot number not reported). There was no concomitant medication. The physician was reporting the patient was referred to her by primary care physician for evaluation on 20-JUN-2012 of persistent left arm paresthesia and muscle weakness following the first dose of GARDASIL in December 2011. The left arm pain diminished after 1 week, but muscle weakness, especially involving the pronator and supinator muscles and paresthesia had persisted. Therapy with GARDASIL was discontinued. There was no treatment given for persistent left arm paresthesia, muscle weakness, especially involving the pronator and supinator muscles and the left arm pain. At the time of the report the patient''s outcome was recovering. Vascular studies were performed on an unknown date, with a result of negative for thrombus. The patient sought medical attention via office visit. Therapy with GARDASIL was not reintroduced. Persistent left arm paresthesia, muscle weakness, especially involving the pronator and supinator muscles and left arm pain were considered to be disabling by the reporter. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166